Study of PF-07275315 for moderate-to-severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had moderate-to-severe asthma for at least 12 months.
- You have had at least one asthma attack in the last 2 years that required steroid pills or injections.
- Your lung function (FEV1) is between 30% and 80% of what is expected for your age and height.
- Your asthma improves by at least 12% after using a rescue inhaler.
- You are currently using a combination inhaler (like a steroid plus a long-acting bronchodilator) at a medium or high dose for at least 6 months.
- You have not used certain biologic treatments (like Xolair, Dupixent, or Nucala) or JAK inhibitors for asthma or other allergic conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an experimental medicine (PF-08103402) to see how well it is tolerated and how it acts in the body, in healthy adults and in people with mild-to-moderate asthma. Participation may help researchers learn if this treatment could help manage asthma symptoms.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.